glp-1 news 2025 november trends 2025: real-world data, patient outcomes & future therapies November in review: GLP-1 breakthroughs,

Retatrutide does not have a brand name yet

They also believe GLP-1 coverage would enhance employees' health and perception of healthcare benefits: 79% agree that GLP-1 coverage will help employees' health long term 77% agree that GLP-1 coverage would make employees feel they get a better health insurance package What employers already covering GLP-1s have to say Companies already covering GLP-1s (25%) say they plan to continue covering them (99%), providing perspective on balancing financial impact with employee engagement and satisfaction

If not addressed, stomach paralysis may lead to malnutrition, dehydration, and blood sugar complications

They also recommend limiting intake of saturated fat, sweets, sugar-sweetened beverages, and red meat

In vitro, GLP-1GIPLani had indistinguishable effects on incretin receptor signalling compared with its GLP-1GIP co-agonist backbone, and this was verified by equal potentiation of glucose-stimulated insulin secretion in isolated mouse islets (Fig